Development and validation a radiomics combined clinical model predicts treatment response for esophageal squamous cell carcinoma patients.

Journal: BMC gastroenterology
PMID:

Abstract

PURPOSE: This study is aimed to develop and validate a machine learning model, which combined radiomics and clinical characteristics to predicting the definitive chemoradiotherapy (dCRT) treatment response in esophageal squamous cell carcinoma (ESCC) patients.

Authors

  • Xiaoyan Yin
    Department of Graduate, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.
  • Yongbin Cui
    Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.
  • Tonghai Liu
    Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.
  • Zhenjiang Li
    Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China; Shandong Medical Imaging and Radiotherapy Engineering Center (SMIREC), Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Huiling Liu
    Software College, Northeastern University, Shenyang, 110819, China.
  • Xingmin Ma
    System Second Department, North China Institute of Computing Technology, Beijing 100083, China.
  • Xue Sha
    Department of Radiation Oncology, Affiliated Cancer Hospital, The Third Affiliated Teaching Hospital of Xinjiang Medical University, Urumuqi, China.
  • Changsheng Ma
    Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 250117, Jinan, Shandong Province, China. machangsheng_2000@126.com.
  • Dali Han
    Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.
  • Yong Yin
    Department of Radiation Oncology, Shandong Cancer Hospital, Jinan, Shandong, 250117, China.